Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
5
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
astrazeneca
gene therapy
gilead sciences
merck
president trump
albert bourla
alzheimer's disease
biogen
bristol-myers squibb
What
bio
drug
roundup
acquisitions
biggest
ceo
seven
today
albert
american
annual
ash
august
away
biotech
blood
borne
bourla
bringing
build
busy
buy
cancers
ceos
company
company’s
conference
crispr
daniel
days
dc
debut
decisions
devices
diego
drugs
dyne’s
executives
fda
future
Language
unset
unknown
Current search:
pfizer
×
abbvie
×
" san diego blog main "
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More